Disordered Fibrinolytic Activity and its Control

Abstract

Get full access to this article

View all access options for this article.

References

Ablondi

F. B.

Hagan

J. J.

Philips

De Renzo

E. C.

(1959). Inhibition of plasmin, trypsin and streptokinase-activated fibrinolytic system by epsilon aminocaproic acid. Arch. Biochem., 82, 153

Alkjaersig

Fletcher

A. P.

Sherry

(1959). Epsilon aminocaproic acid: An inhibitor of plasminogen activation. J. biol. Chem., 234, 832

Bang

N. U.

Fletcher

A. P.

Alkjaersig

Sherry

(1962). Pathogenesis of the coagulation defect developing during plasma proteolytic (‘fibrinolytic’) states. III Demonstration of abnormal clot structure by electron microscopy. J. clin. Invest. 41, 135

Fletcher

A. P.

(1950). Pathophysiology of thrombolysis, In N.I.H. Conference on thrombolytic agents, p. 148. Edited by Roberts

H. R.

Geraty

J. D.

. Chapel Hill: University of North Carolina Press

Fletcher

A. P.

Alkjaersig

Sherry

(1959a) Pathogenesis of the hemorrhagic diathesis developing during ‘fibrinolytic’ states: The significance of defective fibrin polymerization. J. clin. Invest., 38, 1005. (Abst.)

Fletcher

A. P.

Alkjaersig

Sherry

(1959b) The maintenance of a sustained throm: Bolytic state in man I. Induction and effects. J. clin. Invest., 38, 1096

Johnson

A. J.

Newman

Schoicket

D. P.

(1960). Inhibition of pathological spontaneous proteolysis in man by the intravenous infusion of epsilon aminocaproic acid, an inhibitor of plasminogen activation. Clin. Res. Proc., 8, 17

Von Kaulla

K. N.

Swan

(1958). Clotting deviations in man during cardiac bypass: Fibrinolysis and circulating anticoagulant. J. Thorac. Surg., 36, 519

McNicol

G. P.

Douglas

A. S.

(1962). To be published

10.

McNicol

G. P.

Fletcher

A. P.

Alkjaersig

Sherry

(1961a). Impairment of hemostasis in the urinary tract: The role of urokinase J. Lab. clin. Med., 58, 34

11.

McNicol

G. P.

Fletcher

A. P.

Alkjaersig

Sherry

(1961b) The use of epsilon aminocaproic acid, a potent inhibitor of fibrinolytic activity, in the management of postoperative hematuria. J. Urol. (Baltimore), 86, 829

12.

McNicol

G. P.

Fletcher

A. P.

Alkjaersig

Sherry

(1962a) Plasma amino acid chromatography with ion exchange resin loaded paper: Assay of epsilon aminocaproic acid. J. Lab. clin., Med., 59, 7

13.

McNicol

G. P.

Fletcher

A. P.

Alkjaersig

Sherry

(1962b) The absorption, distribution, and excretion of epsilon aminocaproic acid following oral or intravenous administration to man. J. Lab. clin. Med., 59, 15

14.

Nilsson

I. M.

Sjoerdsma

Waldenstrom

(1960). Antifibrinolytic activity and metabolism of epsilon aminocaproic acid. Lancet, 1, 1322

15.

Scheraga

H. A.

(1958). Thrombin and its interaction with fibrinogen. Ann. N.Y. Acad. Sci., 75, 189

16.

Schneider

C. L.

(1959). Etiology of fibrinopenia: Fibrination-defibrination. Ann. N.Y. Acad. Sci., 75, 634

17.

Sherry

Fletcher

A. P.

Alkjaersig

(1959a) Fibrinolysis and fibrinolytic activity in man. Physiol. Rev., 39, 343

18.

Sherry

Fletcher

A. P.

Alkjaersig

Sawyer

W. D.

(1959b) Epsilon aminocaproic acid. ‘A potent anti-fibrinolytic agent’. Trans. Ass. Amer. Phycns, 72, 62

19.

Soulier

J. P.

Mathey

Le Bollock

A. G.

Daumet

Fayet

(1952). Syndromes hémorragiques mortels avec incoagulabilité totale par défibrination et avec fibrinolyse. I. Au cours des exérèses pulmonaires. Rev. Hémat., 7, 30